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A novel hanging spherical drop system for the
generation of cellular spheroids and high
throughput combinatorial drug screening†
A. I. Neto,a,b C. R. Correia,a,b M. B. Oliveira,a,b M. I. Rial-Hermida,c C. Alvarez-Lorenzo,c
R. L. Reisa,b and J. F. Mano*a,b
We propose a novel hanging spherical drop system for anchoring
arrays of droplets of cell suspension based on the use of bio-
mimetic superhydrophobic ﬂat substrates, with controlled positional
adhesion and minimum contact with a solid substrate. By facing
down the platform, it was possible to generate independent sphe-
roid bodies in a high throughput manner, in order to mimic in vivo
tumour models on the lab-on-chip scale. To validate this system
for drug screening purposes, the toxicity of the anti-cancer drug
doxorubicin in cell spheroids was tested and compared to cells in
2D culture. The advantages presented by this platform, such as
feasibility of the system and the ability to control the size uniform-
ity of the spheroid, emphasize its potential to be used as a new low
cost toolbox for high-throughput drug screening and in cell or
tissue engineering.
Cell-based high throughput screening (HTS) has been pro-
posed as a powerful tool for rapid identification of drug
candidates from large biological and chemical libraries with
desired eﬃcacy, which can accelerate drug discovery.1–4 Most
studies of cell and tissue regulation have relied on the analysis
of cell behaviour in two-dimensional (2D) cell culture models.
However, the 2D model fails to simulate the in vivo cellular
microenvironment, thus compromising cellular functions,
namely metabolic activity, proliferation, diﬀerentiation and
cell death. Eﬀorts to address these limitations led to the
development of three-dimensional (3D) cell culture models
in which cells are grown within an engineered extracellular
matrix (ECM).5 HTS of anticancer drugs is usually performed
using high-density multi-well plates with high-level and
expensive robotic devices for cell seeding and drug
management.6–12 Recent advances in 3D cancer cell culture
have used cellular spheroids as an adequate model, exhibiting
a complex microenvironment similar to tumours in vivo and
comparable drug responses.13–18 Spheroids are self-assembled
spherical clusters of cell colonies cultured in environments
where cell–cell interactions dominate over cell–substrate inter-
actions, and they naturally mimic avascular tumours with
inherent metabolic (dependent on oxygen) and proliferative
(dependent on nutrients) gradients.19
3D spheroids can be easily produced by various simple
methods, namely hanging drop cultures, engineered micro-
fabrication of round-bottom and non-adherent platforms,
microfluidic devices, spinner flasks, NASA rotary culture,
thermo-responsible substrates and 3D scaﬀolds.20 In particu-
lar, the hanging drop cultures oﬀer an accessible and reliable
method for generating higher numbers of spheroids with a
precise and homogeneous size control and suitable compati-
bility for high throughput assays. Current developments in
microarray devices are directed towards further reductions in
sample volumes, increasing analytical throughput and inte-
gration of pre- and post-assay processing. Innovative techno-
logies enable, for example, 384 spheroids to be cultured in a
hanging drop fashion in the same platform.21 However, the
production and utilization of such innovative platforms
require high precision and sophisticated equipment that can
be extremely expensive.
In our group, we made advances in this field, creating an
innovative low-cost platform for individually dispensing minia-
turized biomaterials, cells and culture medium, based on
the use of patterned superhydrophobic (SH) surfaces.22–26
The topography of these SH surfaces exhibit peculiar features
like micro- and nano-hierarchical roughness, leading to low
surface energy, mimicking SH surfaces found in Nature, such
as the lotus leaf.
Herein, we propose the use of flat SH substrates to arrange
arrays of quasi-spherical cell culture droplets with the capa-
bility to build-up 3D spheroids in a high throughput manner,
in order to mimic in vivo tumour models on the lab-on-chip
scale. Droplets of fibroblasts-like cells (L929) suspension are
fixed in defined positions by the action of micro-indentations
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patterned with an array arrangement on polystyrene SH sur-
faces. The SH platform is solely physically modified poly-
styrene (PS),27–33 which guarantees the lack of cytotoxicity and
the chemical stability of the platform. Such platform presents
several advantages compared to the conventional methods
used for spheroid formation. Micro-size droplets (volume of
5 µL) for cellular assays allow drastic reduction of the volume
required for cell growth, while SH surfaces mimic the eﬀect of
rose petals allowing a minimum contact of the liquid to the
surface, avoiding any interference such as protein adsorption
or release of molecules from the platform to the cell culture
media. The cell culture medium can be changed easily without
destroying the micro-tissues since the droplets are tightly
linked to the substrates by strong capillary forces, and drugs or
other molecules can be easily added at any time. Moreover, the
platform is compatible or easily adapted with many analysis
techniques, such as inverted confocal microscopy, in which
droplets of the cell suspension remain inverted on the SH
surface; and high-throughput combinatorial analysis may be
performed in situ using diﬀerent cell densities or drug concen-
trations. The high stability, precise positional and adhesive-
ness of the droplets allow to invert the platform 180°
according to hanging drop approaches. Under this configu-
ration the cells initially suspended in the droplets give rise to
spheroids formed by gravity. The innovation of our system
relies on the spherical geometry (“hanging spherical drop”
method) exhibited by the cell suspension droplets. The size
and composition of each droplet can be easily controlled in an
individual form.
To explore the capability of this platform, the cell behaviour
of 3D spheroids was compared to 2D culture upon being sub-
jected to the eﬀect of various concentrations of doxorubicin.
Cell viability was evaluated using image-based analysis tools to
assess the dose-dependent response of the formed tumour
spheroids to this anticancer drug.
A platform was created following biomimetic principles.34
Polystyrene (PS) superhydrophobic (SH) substrate mimicking
the extreme water repellency of the lotus leaf was patterned
with adhesive micro-indentations (Fig. 1A.II) simulating the
eﬀect of rose petals.35 The low adhesion to droplets on the
lotus leaf is caused by the air pockets formed between cell
papilla (Cassie–Baxter model) while on the rose petal surface
the droplets penetrate into the cuticular folds by capillary
forces (Wenzel model).33
The developed platform was used as a support for arrays of
quasi-spherical droplets of cell suspensions (Fig. 1A.I), for the
generation of fibroblast-like cell spheroids. PS sheets were
treated by a phase separation methodology,36 resulting in a
water contact angle (WCA) higher than 150°, mainly by the
introduction of micro-nano roughness on the surface (Fig. 1A.III).
We hypothesize that the micro-indentations created on low
surface-energy surfaces allow one to confine and stabilize
nearly spherical droplets only on the desired places with
minimum contact area between the droplet and the surface,
even when the surface with cell suspension droplets are turned
upside down (Fig. 1A.IV).
Video 1 (ESI†) shows that the platform can be rotated and
tilted several times and the droplets of cell culture medium
remain fixed with high stability. The volume of droplets
used in the micro-indentations can be fixed on the surfaces,
without compromising the water repellency of the surface.
Increasing the volume deposited in the micro-indentation
decreases the sliding angles as the capillary forces exert a less
adhesion eﬀect onto bigger droplets. The handling and the
movement of the chip, medium exchange and drug delivery to
the droplet could be carried out easily, by simply tilting the
culture plate lid. The platforms were robust enough allowing
successive tilting and the droplets do not slip from the micro-
indentation spots. In this proposed device, the cells are main-
tained in suspension and are confined within independent
miniaturized cell culture droplets surrounded essentially by
the gaseous environment of the device. The platform was fixed
into the lids of polystyrene petri dishes (commercially avail-
able), and the bottom part was filled with cell culture media,
in order to create a saturated environment and avoid evapo-
ration of the droplets (Fig. 1A.V–VI). The gravitational force
applied on the cells in the hanged droplets induced its sedi-
mentation and the formation of cell spheroids after 48 h of
seeding time (Fig. 1A.VII). Each droplet in the chip forms a
singular spheroid with a consistent cell population that is gene-
rated without the need of any scaﬀold or adhesive substances.
Fig. 1 (A.I) Upper view scheme of the SH platform (A.II) patterned with
micro-indentations able to suspend arrays of droplets containing cells.
(A.III) The microstructure of PS SH surface observed by SEM and the
representative image of a water droplet over the surface. (A.IV) Image of
the hanging spherical drops system able to conﬁne droplets on the
desired places with minimum contact area between droplets and the
surface. (A.V) Turning the platform 180°, (A.VI) the cell suspension inside
the droplet (A.VII) leads to the formation of spheroids after 2 days due to
the gravitational force applied to the cells. (A.VIII) Drug-screening tests
by adding the anti-cancer drug, doxorubicin, in the droplets containing
cell spheroids. (B) Live/dead cells assay images after 48 hours of culture
were taken using a confocal microscope of the formation of spheroids.
Distinct cell densities were tested. Scale bar: 200 μm.
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It was possible to produce arrays of individual sedimented
spheroids and test distinct doses of an anti-cancer drug widely
used in drug screening, doxorubicin (Dox), in the same device
(Fig. 1A.VIII). Conventional methods to produce spheroids
have common drawbacks, such as the formation of the spher-
oids with irregular sizes, inaccessible for testing in the plat-
forms and diﬃcult to adapt to HTS platforms. The proposed
hanging spherical drop system allows the growth of homo-
genously sized spheroids in an easy and non-invasive way.
For the proof-of-concept, droplets containing a fibroblast-like
cell suspension were dispensed on the inverted platform in
order to promote the spheroid formation. Using distinct cell
numbers, spheroids with diﬀerent sizes and densities were
obtained (Fig. 1B). The images of the spheroids were taken
using a confocal microscope for precise cell quantification.
The stained spheroids with calcein-AM (corresponding to
green cells) and propidium iodide (corresponding to red cells)
show that after 48 hours of incubation the spheroids were
entirely formed with high survival rates. As expected, the dia-
meter of L929 spheroids increased with increasing cell density,
from 10 000 to 60 000 cells perdroplet. Images of spheroids
with greater cell densities (from 5000 to 60 000 cells per
droplet), taken using a fluorescent microscope, can be
observed in Fig. S1A and B.† The micro-tissues produced by the
gravity-enforced hanging drop method with a density of 40 000
cells per drop present a perfect and uniform integration of
single cells into a compact microstructure (Fig. 2A–C).
Spheroids have become a “gold standard” to investigate the
cellular signalling mechanisms and eﬀects of anti-tumour
agents, mimicking the in vivo situation. Cancer cells live in a
complex microenvironment consisting of non-cancer cells and
tumour stroma. The tumour stroma consists of the basement
membrane, immune cells, ECM, blood vasculature, inflamma-
tory cells and fibroblasts. All are known to contribute to cancer
development. Fibroblasts are the major component in the
stroma and are responsible for the production of cytokines,
ECM and growth factors that promote tumour growth.37 Under
such conditions, fibroblasts can acquire a myofibroblastic
phenotype and make direct cell–cell contact, via gap junction
intercellular communication without intervening in the ECM38–40
(Fig. 2D). However, when the fibroblasts are forced to cluster
into a spheroid shape, they undergo a new pathway of cell acti-
vation beginning a process considered as necrosis-like death,
induced by hypoxia or toxins (Fig. 3A.I and Video 2 of the
ESI†). The limited flow of oxygen and nutrients into the core
compromises the viability of the fibroblasts; as a result, the
viability of the cells decreases with the culture time. For this
reason, a typical spheroid has an outer layer of proliferative
cells, an internal layer of quiescent cells and hypoxic cells in
the core.
The morphogenesis of 2D cell cultures (Fig. 3A.II) was
evaluated along with the spheroid culture, as control. In both
conditions 40 000 cells were used and live/dead cells assay was
performed to determine the cell viability. The images of the
cluster cells were taken using confocal microscopy, in order to
provide accurate quantification of the 3D samples.
The images of 2D cell culture were taken using a fluo-
rescence microscope. With increasing cell culture time, the
cells in 2D monolayer presented higher viability compared to
3D spheroids (Fig. 3B). This can be explained by the fact that
cells cultured in monolayer have a higher surface area to
adhere and proliferate, whereas 3D spheroids are limited to
cell–cell interactions since they are cultured in suspension.
Additionally, cells in monolayers have higher access to the
nutrients of culture media, compared to the necrotic core of
spheroids.
The cellular pathway targeted by a drug, such as doxorubi-
cin (Dox), might diﬀer from 2D to 3D condition. Dox is an
anti-cancer agent widely used in human cancer chemotherapy
Fig. 2 (A) SEM, (B) bright ﬁeld, (C) live/dead cells and (D) dapi/phalloidin
representative images of L929 spheroids after 48 hours of culture. Scale
bar: 100 μm.
Fig. 3 (A.I) Representative images using live/dead cells staining taken
from confocal microscope of individual spheroids up to four days of
culture time, with density of 40 000 cells per droplet. Scale bar: 200 μm.
(A.II) Representative images of L929 monolayer cell culture along the
same time points and cell density. Images using live/dead cells staining
were taken using ﬂuorescent microscope. Scale bar: 50 μm. (B) Quantiﬁ-
cation of the viability of the cells in the spheroids and in the 2D cell cul-
tures. Statistical diﬀerences were marked with (***), which represents
p-value <0.001. To evaluate the statistical diﬀerences related to the pre-
vious time point double (##) and triple symbols (###) were used for
p-value <0.01 and p < 0.001, respectively. All results are presented as
mean ± standard deviation.
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that inhibits RNA and DNA synthesis.41 This drug induces an
alternative cell death mechanism to apoptosis.
Fig. 4 shows the eﬀect of distinct concentrations of Dox on
the cells in spheroids with diﬀerent densities. Diﬀerent
amounts of Dox were introduced into the droplets to assess
the dose-dependent response of the formed tumour spheroids
to this anticancer drug. The viability of the cells in the spher-
oids was measured after 24 hours by a live/dead cells assay
(Fig. 4A). As expected, with the increase of the Dox concen-
tration, cell viability of the spheroids decreased. However,
L929 spheroids show a greater resistance to Dox compared to
the monolayer L929 cultures (Fig. 4B and C).
Recent experiments have confirmed that a tumour spheroid
is more resistant to drugs compared with the corresponding
2D cell cultures.42,43 This increased Dox resistance in the
spheroid cells may be due to cell–cell contact response, internal
protective mechanisms, and/or mass transfer limitations.
Extending the screening of cells in suspension, we
employed the new arrangement to test the behaviour of cells
in an aggregated form that could be useful for high-through-
put monitoring. The proposed methodology could be easily
extended to assess the time response of the cells to multiple
drugs, drug screening on co-cultures, and study the eﬀect of
the gaseous environment on cell behaviour (e.g. hypoxia, nor-
moxia and hyperoxia). In future, it may be possible to adapt
the platform for the study of complex cellular spheroids, com-
posed by two or more cell types, in contact with distinct drugs.
Multicellular spheroids are widely used to be representative of
in vivo avascular tumour regions, and this can represent an
opportunity to mimic aspects of native tumour angiogenesis
in vitro. Furthermore, the vascularization may be evaluated using
these platforms, once spheroids represent the ideal conditions
that lead to the self-assembly of tissues mimicking their
natural in vivo behaviour.
Conclusions
A superhydrophobic biomimetic surface based on the so-
called lotus eﬀect was produced onto which arrays of micro-
indentations were generated to fix cell suspension droplets,
based on the rose petal eﬀect. By facing down the chip, it was
possible to produce arrays of cell spheroids developed by
gravity in the suspended droplets, according to an hanging
spherical drop method. Spheroids provide a 3D cellular
environment, which more accurately recapitulates the in vivo
tumour, and have been used for drug screening tests. Using
this platform, the dose-dependent cytotoxic eﬀect of doxorubi-
cin was measured, and we observed decreasing viability of
the cells with increasing doxorubicin concentrations. The
spheroids also exhibit enhanced resistance to the drug over 2D
standard monolayer cultures. We believe that such a platform
may also have the potential to be used in several biological or
biomedical applications, including in the field of tissue engin-
eering and regenerative medicine, drug discovery, and drug
delivery monitoring.
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